Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Fortress Biotech, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Fortress Biotech, Inc. | d238209d10q.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - Fortress Biotech, Inc. | d238209dex311.htm |
| EX-32.1 - SECTION 906 CEO CERTIFICATION - Fortress Biotech, Inc. | d238209dex321.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - Fortress Biotech, Inc. | d238209dex312.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Coronado Biosciences, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dale Ritter, the Senior Vice President, Finance, Chief Accounting Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| November 14, 2011 | /s/ Dale Ritter | |
| Dale Ritter, Senior Vice President, Finance, Chief Accounting Officer and Acting Chief Financial Officer (Principal Financial Officer) |